From macro- to microfactors in health: Social science approaches in research on sexually transmitted infections
Ruth Kutalek and colleagues share their Perspective on Kipruto Chesang and colleagues' qualitative study of beliefs and practices among healthcare providers managing STIs in Kenya and discuss the value of this type of research for addressing biosocial challenges.
Vyšlo v časopise:
From macro- to microfactors in health: Social science approaches in research on sexually transmitted infections. PLoS Med 15(1): e32767. doi:10.1371/journal.pmed.1002490
Kategorie:
Perspective
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1002490
Souhrn
Ruth Kutalek and colleagues share their Perspective on Kipruto Chesang and colleagues' qualitative study of beliefs and practices among healthcare providers managing STIs in Kenya and discuss the value of this type of research for addressing biosocial challenges.
Zdroje
1. Singer M. Anthropology of Infectious Disease. London: Routledge, 2016
2. Chesang KC, Hornston S, Muhenje O, Saliku T, Mirjahangir J, Vitanen A, et al. Healthcare provider perspectives on managing sexually transmitted infections in HIV care settings in Kenya: A qualitative thematic analysis. PLoS Med. 2017;14(12): e1002480. doi: 10.1371/journal.pmed.1002480
3. Farmer P. Preface. In: Farmer P, Kim JY, Kleinman A, Basilico M. Reimagining Global Health. Berkely: University of California Press. 2013, p. XIV
4. Harper I, Parker M. The politics and anti-politics of infectious disease control. Med Anthro. 2014;33: 198–205. doi: 10.1080/01459740.2014.892484 24761974
5. Ha JF, Anat DS, Longnecker N. Doctor-patient communication: a review. The Ochsner J. 2010;10: 38–43. 21603354
6. Gourlay A, Wringe A, Birdthistle I, Mshana G, Michael D, Urassa M. ‘‘It Is Like That, We Didn’t Understand Each Other”: Exploring the Influence of Patient-Provider Interactions on Prevention of Mother-To-Child Transmission of HIV Service Use in Rural Tanzania. PLoS ONE 2014;9,9: e106325. doi: 10.1371/journal.pone.0106325 25180575
7. Campbell C, Scott K, Skovdal M, Madanhire C, Nyamukapa C, Gregson S. A good patient? How notions of ‘a good patient’ affect patient-nurse relationships and ART adherence in Zimbabwe. BMC Infect Dis. 2015;15: 404. doi: 10.1186/s12879-015-1139-x 26424656
8. McSwiggin CC. 2017. Moral Adherence: HIV Treatment, Undetectability, and Stigmatized Viral Loads among Haitians in South Florida. Med Anthro. 2017;36, 8: 714–728. doi: 10.1080/01459740.2017.1361946 28777660
9. Adams OP, Carter AO, Redwood-Campbell L. Understanding attitudes, barriers and challenges in a small island nation to disease and partner notification for HIV and other sexually transmitted infections: a qualitative study. BMC Publ Health 2015; 15: 455. doi: 10.1186/s12889-015-1794-2 25934557
10. Muessig KE, Smith MK, Maman S, Huang Y, Chen X-S. Advancing the prevention agenda for HIV and other sexually transmitted infections in South China: social science research to inform effective public health interventions. AIDS Behav. 2014;18: 222–231. doi: 10.1007/s10461-014-0695-1 24443101
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2018 Číslo 1
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
Najčítanejšie v tomto čísle
- Traumatic brain injury and the risk of dementia diagnosis: A nationwide cohort study
- Pelvic inflammatory disease risk following negative results from chlamydia nucleic acid amplification tests (NAATs) versus non-NAATs in Denmark: A retrospective cohort
- PD-L1 checkpoint inhibition and anti-CTLA-4 whole tumor cell vaccination counter adaptive immune resistance: A mouse neuroblastoma model that mimics human disease
- Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults